Pharma

France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted...

Panthera Biopartners (Panthera), the LDC-backed UK based clinical trial Site Management Organisation (SMO), has announced the acquisition of Óbudai Egészségügyi Centrum Kft (OEC), a...

Alcami Corporation, a US-based CDMO, is acquiring Tjoapack, a Netherlands-based global contract packaging organisation (CPO) serving the pharmaceutical and biotech industries. Ampersand Capital Partners...

Kurma Partners, a European healthcare venture capital firm and a Eurazeo group company, has announced the final closing of Biofund IV at €215m (US$252m),...

InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands...

Singapore-based private equity firm Everstone Capital has partnered with the founding promoters of India-based Apothecon and US-based Navinta, investing close to US$270m for a...

The British Business Bank, the UK government’s economic development bank, has agreed to make a £100m (US$135.5m) commitment to Apposite Healthcare Growth I, a...

Adcendo, a Denmark-based biotech company focused on the development of first-and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical...

Nasdaq-listed biopharmaceutical company, Gilead Sciences, is acquiring Germany-based Tubulis, for a total deal value of up to US$5bn. Under the terms of the agreement, Gilead...

Jeito Capital, an independent private equity fund dedicated to biopharma, has announced the final close of its second fund Jeito II, exceeding its €1bn...